Tekni-Plex Inc. (Wayne, PA) has announced a $15 million investment in a new state-of-the-art manufacturing facility in Suzhou, China. It represents the single largest recent investment by the globally integrated company, which specializes in developing and manufacturing packaging materials, medical compounds and medical tubing. Production for some product lines has already begun at the new facility, which will replace an existing plant, also in Suzhou, where the company has operated since 2005.
Initially, the more than 140,000-square-foot facility will manufacture products for Tekni-Plex’s Natvar, Colorite and Action Technology business units. Three Class 100,000 cleanrooms to accommodate medical-grade tubing and components production plus one Class 10,000 cleanroom for the production of Natvar’s pharma-grade tubing will be on site.
The facility also will produce Natvar’s recently announced silicone extrusion tubing for catheters, feeding tubes, drug delivery and peristaltic pump applications, as well as microextrusion tubing that targets a variety of demanding neurovascular interventional therapies and surgical applications. Colorite custom compounds for medical device applications and Action Technology’s dip tubes used in food/beverage, pharmaceutical, personal care, industrial and household pump applications will be produced at the plant, as well.
The investment in China represents another step in Tekni-Plex’s commitment to support customers with robust global supply, said CEO Paul Young. “Pharmaceutical, medical device and other manufacturers want access to exactly the same components and materials regardless of where in the world their manufacturing facility is located. It is our goal to meet those objectives,” he added.
Celebrating its 50th anniversary, Tekni-Plex operates 30 manufacturing sites across eight countries worldwide to meet the needs of its global customers.
Colorite and Natvar are exhibiting at the co-located PLASTEC East and MD&M East event in New York, NY, from June 13 to 15. Visit them in booths 1445 and 1433, respectively.